✦ LIBER ✦

New desensitization regimen with mesalamine granules in a patient with ulcerative colitis and mesalamine intolerance

✍ Scribed by Pantelis Oustamanolakis; Ioannis E. Koutroubakis

Publisher: John Wiley and Sons
Year: 2011
Tongue: English
Weight: 45 KB
Volume: 17
Category: Article
ISSN: 1078-0998
DOI: 10.1002/ibd.21323

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Mesalamine-induced pleuritis in a patien

Mesalamine-induced pleuritis in a patient with ulcerative colitis

✍ Alessandro Tozzi; Maria Rosa Biagini; Carlotta Rastelli; Andrea Galli; Donatella 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 46 KB 👁 1 views

Toxic epidermal necrosis associated with

Toxic epidermal necrosis associated with mesalamine in a patient with ulcerative colitis

✍ Ken Fukunaga; Yoshio Ohda; Taku Inoue; Tomoaki Kono; Hiroto Miwa; Takayuki Matsu 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 101 KB 👁 2 views

On 20 July 2006 a 17-year-old male was admitted to our critical care unit for the treatment of painful eruptions on his trunk, resembling toxic epidermal necrosis (TEN). On 13 June 2006 he had been diagnosed with ulcerative colitis (UC) and was hospitalized on 28 June 2006 for treatment of an acute

Direct comparison of two different mesal

Direct comparison of two different mesalamine formulations for the induction of remission in patients with ulcerative colitis: A double-blind, randomized study

✍ Hiroaki Ito; Mitsuo Iida; Takayuki Matsumoto; Yasuo Suzuki; Hidetaka Sasaki; Toy 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 131 KB 👁 1 views

Background: Mesalamine is the first-line drug for the treatment of ulcerative colitis (UC). We directly compared the efficacy and safety of two mesalamine formulations for the induction of remission in patients with UC. ## Methods: In a multicenter, double-blind, randomized study, 229 patients wit

Direct comparison of two different mesal

Direct comparison of two different mesalamine formulations for the maintenance of remission in patients with ulcerative colitis: A double-blind, randomized study

✍ Hiroaki Ito; Mitsuo Iida; Takayuki Matsumoto; Yasuo Suzuki; Yoshiyuki Aida; Toyo 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 240 KB 👁 1 views

Background: Mesalamine has been used as the first-line medication for the treatment of ulcerative colitis (UC). We directly compared the efficacy and safety of two different mesalamine formulations in the maintenance of remission in patients with UC. ## Methods: In a multicenter, double-blind, ran